Ally Bridge Group (NY) LLC Historic Quarter Change: USA Options, Sold Out

Ally Bridge Group (NY) LLC historic quarter change: USA Options, Sold out

In put and call options, at their filed underlying value (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Ally Bridge Group (NY) LLC opened 13 positions, added to 1, reduced 2 and sold out of 12.

Q2 2026: Stock SLNO; Country of operation United States; Class COM · Put; Shares before 200,000.
Q2 2026: Stock CMPX; Country of operation United States; Class COM · Call; Shares before 1,000,000.
Q2 2026: Stock QURE; Country of operation —; Class SHS · Call; Shares before 300,000.
Q2 2026: Stock MAZE; Country of operation United States; Class COM · Call; Shares before 100,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1822947), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-18); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2020-12-31.

Quarter	Stock	Country of operation	Class	Shares before	Share change	Value before	Value after	Value change	Filed
Q2 2026	SLNO SOLENO THERAPEUTICS INC	United States	COM · Put	200,000	-200,000	$6,696,000	$0	-$6,696,000	2026-08-14
Q2 2026	CMPX COMPASS THERAPEUTICS INC	United States	COM · Call	1,000,000	-1,000,000	$5,290,000	$0	-$5,290,000	2026-08-14
Q2 2026	QURE UNIQURE NV		SHS · Call	300,000	-300,000	$4,905,000	$0	-$4,905,000	2026-08-14
Q2 2026	MAZE MAZE THERAPEUTICS INC	United States	COM · Call	100,000	-100,000	$2,985,000	$0	-$2,985,000	2026-08-14
Q2 2026	REPL REPLIMUNE GROUP INC	United States	COM · Call	246,900	-246,900	$1,888,785	$0	-$1,888,785	2026-08-14
Q2 2026	KPTI KARYOPHARM THERAPEUTICS INC	United States	COM NEW · Call	250,000	-250,000	$1,392,500	$0	-$1,392,500	2026-08-14
Q1 2026	EWTX EDGEWISE THERAPEUTICS INC	United States	COM · Put	250,000	-250,000	$6,203,750	$0	-$6,203,750	2026-05-18
Q1 2026	TSHA TAYSHA GENE THERAPIES INC	United States	COM SHS · Call	500,000	-500,000	$2,750,000	$0	-$2,750,000	2026-05-18
Q4 2025	SLNO SOLENO THERAPEUTICS INC	United States	COM · Call	250,000	-250,000	$16,900,000	$0	-$16,900,000	2026-02-17
Q4 2025	PRAX PRAXIS PRECISION MEDICINES I	United States	COM NEW · Call	100,000	-100,000	$5,300,000	$0	-$5,300,000	2026-02-17
Q4 2025	MLTX MOONLAKE IMMUNOTHERAPEUTICS	Switzerland	CLASS A ORD · Call	69,000	-69,000	$494,730	$0	-$494,730	2026-02-17
Q4 2025	ATYR ATYR PHARMA INC	United States	COM NEW · Call	600,000	-600,000	$432,840	$0	-$432,840	2026-02-17

Similar Firms

Firm Name	Country	13F Value	Holdings
Marcho Partners LLP	United Kingdom	$0.124B	5
WJ Financial Advisors LLC	United States	$0.124B	128
Vigil Wealth Management, LLC	United States	$0.124B	75
Family Legacy Financial Solutions, LLC	United States	$0.124B	48
Post Resch Tallon Group Inc.	United States	$0.124B	120
EDMP, INC.	United States	$0.124B	71
INTREPID FAMILY OFFICE LLC	United States	$0.124B	38
Clarity Retirement & Wealth, LLC	United States	$0.124B	27
R.H. Dinel Investment Counsel, Inc.	United States	$0.124B	40
NorthLanding Financial Partners, LLC	United States	$0.124B	41